DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Fundamental Analysis & Valuation

FRA:DBAN • DE000A1TNUT7

24.55 EUR
0 (0%)
Last: Mar 6, 2026, 10:30 AM

This DBAN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

DBAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 117 industry peers in the Capital Markets industry. While DBAN is still in line with the averages on profitability rating, there are concerns on its financial health. DBAN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. DBAN.DE Profitability Analysis

1.1 Basic Checks

  • DBAN had positive earnings in the past year.
  • DBAN had a positive operating cash flow in the past year.
  • In multiple years DBAN reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: DBAN reported negative operating cash flow in multiple years.
DBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFDBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • DBAN has a Return On Assets of 3.38%. This is in the better half of the industry: DBAN outperforms 64.10% of its industry peers.
  • Looking at the Return On Equity, with a value of 4.81%, DBAN is in line with its industry, outperforming 45.30% of the companies in the same industry.
  • DBAN has a Return On Invested Capital (2.53%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.38%
ROE 4.81%
ROIC 2.53%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
DBAN.DE Yearly ROA, ROE, ROICDBAN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • DBAN has a better Profit Margin (31.10%) than 78.63% of its industry peers.
  • In the last couple of years the Profit Margin of DBAN has declined.
  • With a decent Operating Margin value of 32.22%, DBAN is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DBAN has declined.
  • Looking at the Gross Margin, with a value of 89.98%, DBAN belongs to the top of the industry, outperforming 90.60% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DBAN has remained more or less at the same level.
Industry RankSector Rank
OM 32.22%
PM (TTM) 31.1%
GM 89.98%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
DBAN.DE Yearly Profit, Operating, Gross MarginsDBAN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

3

2. DBAN.DE Health Analysis

2.1 Basic Checks

  • DBAN has less shares outstanding than it did 1 year ago.
  • DBAN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DBAN has a worse debt to assets ratio.
DBAN.DE Yearly Shares OutstandingDBAN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DBAN.DE Yearly Total Debt VS Total AssetsDBAN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.77, we must say that DBAN is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.77, DBAN is in the better half of the industry, outperforming 68.38% of the companies in the same industry.
  • The Debt to FCF ratio of DBAN is 93.97, which is on the high side as it means it would take DBAN, 93.97 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 93.97, DBAN is doing good in the industry, outperforming 64.10% of the companies in the same industry.
  • DBAN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.31, DBAN is in the better half of the industry, outperforming 68.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 93.97
Altman-Z 1.77
ROIC/WACCN/A
WACCN/A
DBAN.DE Yearly LT Debt VS Equity VS FCFDBAN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • DBAN has a Current Ratio of 0.84. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of DBAN (0.84) is comparable to the rest of the industry.
  • DBAN has a Quick Ratio of 0.84. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DBAN has a Quick ratio (0.84) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
DBAN.DE Yearly Current Assets VS Current LiabilitesDBAN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. DBAN.DE Growth Analysis

3.1 Past

  • DBAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.70%.
  • Measured over the past years, DBAN shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.13% on average per year.
  • Looking at the last year, DBAN shows a very negative growth in Revenue. The Revenue has decreased by -10.87% in the last year.
  • Measured over the past years, DBAN shows a small growth in Revenue. The Revenue has been growing by 7.25% on average per year.
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%

3.2 Future

  • DBAN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -22.84% yearly.
  • The Revenue is expected to decrease by -6.93% on average over the next years.
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5Y-22.84%
Revenue Next Year-22.08%
Revenue Next 2Y-16.59%
Revenue Next 3Y-7.69%
Revenue Next 5Y-6.93%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DBAN.DE Yearly Revenue VS EstimatesDBAN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 50M -50M 100M 150M 200M
DBAN.DE Yearly EPS VS EstimatesDBAN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5

4

4. DBAN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • DBAN is valuated correctly with a Price/Earnings ratio of 16.82.
  • Based on the Price/Earnings ratio, DBAN is valued a bit cheaper than 69.23% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.74. DBAN is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 12.20, which indicates a correct valuation of DBAN.
  • Based on the Price/Forward Earnings ratio, DBAN is valued cheaper than 82.91% of the companies in the same industry.
  • DBAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.82.
Industry RankSector Rank
PE 16.82
Fwd PE 12.2
DBAN.DE Price Earnings VS Forward Price EarningsDBAN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DBAN indicates a somewhat cheap valuation: DBAN is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 224.48
EV/EBITDA N/A
DBAN.DE Per share dataDBAN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as DBAN's earnings are expected to decrease with -15.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%

5

5. DBAN.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.02%, DBAN is a good candidate for dividend investing.
  • DBAN's Dividend Yield is a higher than the industry average which is at 3.08.
  • Compared to an average S&P500 Dividend Yield of 1.82, DBAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

  • The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
DBAN.DE Yearly Dividends per shareDBAN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 73.85% of the earnings are spent on dividend by DBAN. This is not a sustainable payout ratio.
  • DBAN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.85%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
DBAN.DE Yearly Income VS Free CF VS DividendDBAN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
DBAN.DE Dividend Payout.DBAN.DE Dividend Payout, showing the Payout Ratio.DBAN.DE Dividend Payout.PayoutRetained Earnings

DBAN.DE Fundamentals: All Metrics, Ratios and Statistics

DEUTSCHE BETEILIGUNGS AG

FRA:DBAN (3/6/2026, 10:30:13 AM)

24.55

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-06
Earnings (Next)03-10
Inst Owners11.66%
Inst Owner ChangeN/A
Ins Owners38.61%
Ins Owner ChangeN/A
Market Cap461.54M
Revenue(TTM)96.86M
Net Income(TTM)30.13M
Analysts86.15
Price Target36.81 (49.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP73.85%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.03%
PT rev (3m)-6.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.82
Fwd PE 12.2
P/S 4.76
P/FCF 224.48
P/OCF 174.5
P/B 0.74
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)1.46
EY5.95%
EPS(NY)2.01
Fwd EY8.2%
FCF(TTM)0.11
FCFY0.45%
OCF(TTM)0.14
OCFY0.57%
SpS5.15
BVpS33.3
TBVpS30.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.08
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 4.81%
ROCE 3.86%
ROIC 2.53%
ROICexc 2.68%
ROICexgc 2.85%
OM 32.22%
PM (TTM) 31.1%
GM 89.98%
FCFM 2.12%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-35.11%
ROICexgc growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 93.97
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 6.82%
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 1.77
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5Y-22.84%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%
Revenue Next Year-22.08%
Revenue Next 2Y-16.59%
Revenue Next 3Y-7.69%
Revenue Next 5Y-6.93%
EBIT growth 1Y-37.36%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-64.73%
EBIT Next 3Y-9.54%
EBIT Next 5Y-15.44%
FCF growth 1Y109.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.05%
OCF growth 3YN/A
OCF growth 5YN/A

DEUTSCHE BETEILIGUNGS AG / DBAN.DE FAQ

What is the ChartMill fundamental rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to DBAN.DE.


What is the valuation status of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to DEUTSCHE BETEILIGUNGS AG (DBAN.DE). This can be considered as Fairly Valued.


What is the profitability of DBAN stock?

DEUTSCHE BETEILIGUNGS AG (DBAN.DE) has a profitability rating of 4 / 10.


What is the financial health of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

The financial health rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is 3 / 10.


What is the earnings growth outlook for DEUTSCHE BETEILIGUNGS AG?

The Earnings per Share (EPS) of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is expected to decline by -71.64% in the next year.